Choice Hotels International, Inc.

MGM Resorts International

Neo-Concept International Group Holdings Limited Class A

mF International Limited Class A

Trio-Tech International

Vornado Realty Trust

Byrna Technologies, Inc.

Albany International Corporation

CompX International Inc.

Short interest: 20.56% of float, squeeze risk: HIGH

Dilution score: 21/100 (LOW), 24.0 months cash

10 PubMed publications found for Choice Hotels International, .

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part I-Guidelines on Intranasal Treatments.

Comparative Efficacy of Talquetamab vs. Real-World Physician's Choice of Treatment in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma: Updated Analyses of MonumenTAL-1 vs. LocoMMotion/MoMMent.

Advantages and Challenges of Platform Trials for Disease Modifying Therapies in Parkinson's Disease.

Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma.

ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update.

11 PubMed publications found for Choice Hotels International, .

Cilta-cel in lenalidomide-refractory multiple myeloma (CARTITUDE-4): an updated analysis including overall survival from an open-label, multicentre, randomised, phase 3 trial.

Short interest: 20.55% of float, squeeze risk: HIGH

Short interest: 18.98% of float, squeeze risk: MODERATE

Dilution score: 16/100 (LOW), 999.0 months cash

SW convergence: 50/100 (Neutral), 0 bullish / 0 bearish signals

Short interest: 17.7% of float, squeeze risk: MODERATE

Dilution score: 13/100 (LOW), 999.0 months cash

Short interest: 18.21% of float, squeeze risk: MODERATE

SW convergence: 50/100 (Neutral), 1 bullish / 1 bearish signals

Short interest: 18.16% of float, squeeze risk: MODERATE

Short interest: 17.75% of float, squeeze risk: MODERATE

Short interest: 17.96% of float, squeeze risk: MODERATE

<article class="bts-verified-summary" data-ticker="CHH">
<p>Choice Hotels International, Inc. Common Stock (CHH) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.</p>
<p>CHH has 1 Form 4 insider filing recorded at the SEC in the past 30 days<sup><a href="#fn-1">[1]</a></sup>.</p>
<section class="sources" data-nosnippet aria-label="Sources"><h3>Sources</h3><ol><li id="fn-1">SEC EDGAR · 0001046311 (2026-04-11) <a href="https://efts.sec.gov/LATEST/search-index?q=%22CHH%22&amp;forms=4&amp;dateRange=custom&amp;startdt=2026-03-12&amp;enddt=2026-04-11" rel="nofollow noopener noreferrer">↗</a></li></ol></section>
</article>

Choice Hotels International, Inc. Common Stock

SEC EDGAR — 0001046311

Choice Hotels International, Inc. Common Stock (CHH) — BioTechSigns Verified Summary

Choice Hotels International, Inc. Common Stock (CHH) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.

CHH has 1 Form 4 insider filing recorded at the SEC in the past 30 days[1].

Sources:
[1] SEC EDGAR, 0001046311. Source last updated 2026-04-11, retrieved 2026-04-11.
    https://efts.sec.gov/LATEST/search-index?q=%22CHH%22&forms=4&dateRange=custom&startdt=2026-03-12&enddt=2026-04-11